Suppr超能文献

[百因止P/N生产中的纳滤:提高病毒清除能力同时保持产品质量]

[Nanofiltration in production of Beriplex P/N: increasing the capacity of virus elimination while maintaining product quality].

作者信息

Römisch J, Gröner A, Bernhardt D, Diehl K H, Hein B, List W, Müller H G, Nowak T, Ronneberger H, Schüler E, Weimer T, Hilfenhaus J

机构信息

Centeon Pharma GmbH, Marburg/Lahn, Deutschland.

出版信息

Beitr Infusionsther Transfusionsmed. 1996;33:220-4.

PMID:8974698
Abstract

For the manufacture of the PCC Beriplex P/N, nanofiltration was introduced into the production process of Beriplex HS providing an additional means to heat treatment for the clearance/inactivation of viruses. By nanofiltration, large enveloped viruses (HSV-1, HIV-1) were completely eliminated by a factor of more than 7 log10. While medium-sized enveloped viruses (HBV, BVDV) were cleared by a factor of approximately 4 log10, small non-enveloped viruses (poliovirus) were not removed. The product profile remained, no thrombogenic activities were detected.

摘要

为了生产凝血因子复合物百因止P/N,纳滤被引入到百因止HS的生产过程中,为病毒清除/灭活的热处理提供了额外手段。通过纳滤,大型包膜病毒(单纯疱疹病毒1型、人类免疫缺陷病毒1型)被完全清除,清除率超过7个对数级。中型包膜病毒(乙肝病毒、牛病毒性腹泻病毒)的清除率约为4个对数级,而小型无包膜病毒(脊髓灰质炎病毒)未被清除。产品特性保持不变,未检测到血栓形成活性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验